How Can A Contract Development And Manufacturing Organization Advance A Cell & Gene Therapy Product?

There is no one-size-fits-all answer for cell and gene therapy developers seeking to determine why, and more importantly when, to outsource manufacturing or process development to a CDMO. Each developer will have unique needs depending largely on the stage of their technology. For instance, a pre-clinical company will have vastly different needs from a company in Phase III clinical trials. For every developer, however, the substantial risks associated with changing a process later in development should drive early engagement. In general, a good time to start talking to a CDMO is prior to moving from the pre-clinical stage into manufacturing for clinical trials.

This blog covers the services and benefits of working with a CDMO to help you through the process.